tsh biopharmoration Ltd (8432) — Cash Flow Reinvestment Rate
tsh biopharmoration Ltd (8432) has a Cash Flow Reinvestment Rate of 0.08x as of June 2025, reinvesting NT$3.27 Million (capex NT$3.27 Million ) from operating cash flow of NT$42.55 Million. See 8432 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
tsh biopharmoration Ltd Cash Flow Reinvestment Rate (2017–2024)
Historical reinvestment intensity for tsh biopharmoration Ltd across 8 annual periods. For the full cash flow conversion analysis, see 8432 cash flow conversion.
Annual Cash Flow Reinvestment Rate for tsh biopharmoration Ltd (2017–2024)
Year-by-year capital reinvestment analysis for tsh biopharmoration Ltd. See 8432 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.71x | NT$130.68 Million | NT$183.77 Million | NT$2.74 Million | ▼ -85.5% |
| 2023 | 4.92x | NT$166.57 Million | NT$33.87 Million | NT$5.56 Million | ▲ +297.7% |
| 2022 | 1.24x | NT$42.48 Million | NT$34.35 Million | NT$18.73 Million | ▲ +479.4% |
| 2021 | 0.21x | NT$14.66 Million | NT$68.71 Million | NT$382.00K | ▼ -98.9% |
| 2020 | 19.96x | NT$231.81 Million | NT$11.61 Million | NT$2.38 Million | ▲ +7837.8% |
| 2019 | 0.25x | NT$22.30 Million | NT$88.65 Million | NT$3.00 Million | ▼ -90.3% |
| 2018 | 2.59x | NT$162.16 Million | NT$62.62 Million | NT$5.88 Million | ▲ +74.7% |
| 2017 | 1.48x | NT$120.29 Million | NT$81.13 Million | NT$4.57 Million | — |